vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.

SMITH & WESSON BRANDS, INC. is the larger business by last-quarter revenue ($124.7M vs $83.1M, roughly 1.5× PROCEPT BioRobotics Corp). SMITH & WESSON BRANDS, INC. runs the higher net margin — 1.5% vs -38.1%, a 39.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -3.9%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -4.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.

PRCT vs SWBI — Head-to-Head

Bigger by revenue
SWBI
SWBI
1.5× larger
SWBI
$124.7M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+24.1% gap
PRCT
20.2%
-3.9%
SWBI
Higher net margin
SWBI
SWBI
39.6% more per $
SWBI
1.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-4.8%
SWBI

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
PRCT
PRCT
SWBI
SWBI
Revenue
$83.1M
$124.7M
Net Profit
$-31.6M
$1.9M
Gross Margin
64.9%
24.3%
Operating Margin
-4.1%
3.3%
Net Margin
-38.1%
1.5%
Revenue YoY
20.2%
-3.9%
Net Profit YoY
-27.9%
-53.6%
EPS (diluted)
$-0.56
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SWBI
SWBI
Q1 26
$83.1M
Q4 25
$76.4M
$124.7M
Q3 25
$83.3M
$85.1M
Q2 25
$79.2M
$140.8M
Q1 25
$69.2M
$115.9M
Q4 24
$68.2M
$129.7M
Q3 24
$58.4M
$88.3M
Q2 24
$53.4M
$159.1M
Net Profit
PRCT
PRCT
SWBI
SWBI
Q1 26
$-31.6M
Q4 25
$-29.8M
$1.9M
Q3 25
$-21.4M
$-3.4M
Q2 25
$-19.6M
$8.6M
Q1 25
$-24.7M
$2.1M
Q4 24
$-18.9M
$4.5M
Q3 24
$-21.0M
$-1.9M
Q2 24
$-25.6M
$27.9M
Gross Margin
PRCT
PRCT
SWBI
SWBI
Q1 26
64.9%
Q4 25
60.6%
24.3%
Q3 25
64.8%
25.9%
Q2 25
65.4%
28.8%
Q1 25
63.9%
24.1%
Q4 24
64.0%
26.6%
Q3 24
63.2%
27.4%
Q2 24
59.0%
35.5%
Operating Margin
PRCT
PRCT
SWBI
SWBI
Q1 26
-4.1%
Q4 25
-40.6%
3.3%
Q3 25
-27.8%
-3.5%
Q2 25
-28.0%
9.3%
Q1 25
-39.7%
4.1%
Q4 24
-28.9%
5.8%
Q3 24
-38.4%
-1.7%
Q2 24
-50.3%
17.4%
Net Margin
PRCT
PRCT
SWBI
SWBI
Q1 26
-38.1%
Q4 25
-39.1%
1.5%
Q3 25
-25.7%
-4.0%
Q2 25
-24.7%
6.1%
Q1 25
-35.8%
1.8%
Q4 24
-27.6%
3.5%
Q3 24
-35.9%
-2.1%
Q2 24
-48.0%
17.5%
EPS (diluted)
PRCT
PRCT
SWBI
SWBI
Q1 26
$-0.56
Q4 25
$-0.54
$0.04
Q3 25
$-0.38
$-0.08
Q2 25
$-0.35
$0.19
Q1 25
$-0.45
$0.05
Q4 24
$-0.34
$0.10
Q3 24
$-0.40
$-0.04
Q2 24
$-0.50
$0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SWBI
SWBI
Cash + ST InvestmentsLiquidity on hand
$245.6M
$22.4M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$363.2M
Total Assets
$487.1M
$548.6M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SWBI
SWBI
Q1 26
$245.6M
Q4 25
$286.5M
$22.4M
Q3 25
$294.3M
$18.0M
Q2 25
$302.7M
$25.2M
Q1 25
$316.2M
$26.7M
Q4 24
$333.7M
$39.1M
Q3 24
$196.8M
$35.5M
Q2 24
$214.1M
$60.8M
Total Debt
PRCT
PRCT
SWBI
SWBI
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
SWBI
SWBI
Q1 26
$347.7M
Q4 25
$365.9M
$363.2M
Q3 25
$380.3M
$364.4M
Q2 25
$385.8M
$372.5M
Q1 25
$389.2M
$366.9M
Q4 24
$402.2M
$371.5M
Q3 24
$241.2M
$380.0M
Q2 24
$251.8M
$399.9M
Total Assets
PRCT
PRCT
SWBI
SWBI
Q1 26
$487.1M
Q4 25
$508.1M
$548.6M
Q3 25
$511.5M
$554.6M
Q2 25
$513.1M
$559.6M
Q1 25
$519.4M
$578.9M
Q4 24
$534.0M
$587.4M
Q3 24
$374.1M
$571.3M
Q2 24
$374.4M
$577.4M
Debt / Equity
PRCT
PRCT
SWBI
SWBI
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
SWBI
SWBI
Operating Cash FlowLast quarter
$27.3M
Free Cash FlowOCF − Capex
$16.3M
FCF MarginFCF / Revenue
13.1%
Capex IntensityCapex / Revenue
8.8%
Cash ConversionOCF / Net Profit
14.22×
TTM Free Cash FlowTrailing 4 quarters
$21.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
SWBI
SWBI
Q1 26
Q4 25
$-10.3M
$27.3M
Q3 25
$-6.6M
$-8.1M
Q2 25
$-15.0M
$40.8M
Q1 25
$-17.0M
$-9.8M
Q4 24
$-32.4M
$-7.4M
Q3 24
$-18.8M
$-30.8M
Q2 24
$-15.7M
$43.7M
Free Cash Flow
PRCT
PRCT
SWBI
SWBI
Q1 26
Q4 25
$-12.2M
$16.3M
Q3 25
$-9.5M
$-12.4M
Q2 25
$-17.8M
$33.5M
Q1 25
$-18.8M
$-16.1M
Q4 24
$-33.6M
$-10.7M
Q3 24
$-19.0M
$-35.5M
Q2 24
$-16.8M
$38.2M
FCF Margin
PRCT
PRCT
SWBI
SWBI
Q1 26
Q4 25
-15.9%
13.1%
Q3 25
-11.4%
-14.6%
Q2 25
-22.5%
23.8%
Q1 25
-27.2%
-13.9%
Q4 24
-49.2%
-8.3%
Q3 24
-32.6%
-40.2%
Q2 24
-31.4%
24.0%
Capex Intensity
PRCT
PRCT
SWBI
SWBI
Q1 26
Q4 25
2.4%
8.8%
Q3 25
3.4%
5.0%
Q2 25
3.5%
5.2%
Q1 25
2.7%
5.4%
Q4 24
1.7%
2.5%
Q3 24
0.4%
5.3%
Q2 24
2.0%
3.5%
Cash Conversion
PRCT
PRCT
SWBI
SWBI
Q1 26
Q4 25
14.22×
Q3 25
Q2 25
4.73×
Q1 25
-4.68×
Q4 24
-1.63×
Q3 24
Q2 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

SWBI
SWBI

Segment breakdown not available.

Related Comparisons